• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

F
Fabbro E.	-	PROTHROMBOTIC FACTORS AND OXIDATIVE STRESS MARKERS IN A TYPE 2 DIABETES POPULATION
Fabbro-Peray P.	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
Fabri D.R.	-	THE ROLE OF FACTOR VIII IN THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN MURINE MODELS
	-	DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE
Fabris F.	-	THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES
	-	THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS
	-	HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Facchiano A.	-	THROMBIN-MEDIATED IMPAIRMENT OF FGF-2 ACTIVITY
Facchini M.	-	CANOLA OIL, BUT NOT SUNFLOWER OIL, DECREASES CHOLESTEROL AND IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE: A DOUBLE-BLIND, RANDOMIZED INTERVENTIONAL STUDY
Faccinetto C.	-	P2X1 RECEPTORS AS NEW REGULATORS OF NEUTROPHIL LIFE SPAN
	-	ATP VIA P2X7 MODULATES THE TLR-DEPENDENT EXPRESSION AND ACTIVITY OF HUMAN NEUTROPHIL INFLAMMASOME
Fadin M.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Fagnani D.	-	D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY
Fahs S.A.	-	TRANSPLANT BONE MARROW THAT IS GENETICALLY MODIFIED TO EXPRESS FVIII ONLY IN PLATELETS CAN RESTORE HEMOSTASIS TO HEMOPHILIA A MICE ON A STRONG INHIBITOR BACKGROUND
Faioni E.M.	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
Falanga A.	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
	-	DIFFERENTIAL EFFECTS OF RETINOIDS ON THE PROCOAGULANT ACTIVITY (PCA) AND CYTO-DIFFERENTIATION OF LEUKEMIC CELLS FRESHLY ISOLATED FROM ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS
	-	ALL-TRANS RETINOIC ACID (ATRA) INHIBITS ENDOTHELIAL ANGIOGENESIS INDUCED BY TUMOR CELLS AND STANDARD FACTORS
	-	PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) DALTEPARIN REDUCES THE PROTHROMBOTIC AND PROANGIOGENIC POTENTIAL OF MICROVASCULAR ENDOTHELIAL CELLS ELICITED BY TUMOR CELLS
Falchi M.	-	PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
Falciani M.	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Falcinelli E.	-	A NEW CASE OF ACQUIRED GLANZMANN'S THROMBASTHENIA: COMPARATIVE EVALUATION OF THE DIAGNOSTIC VALUE OF DIFFERENT PLATELET FUNCTION TESTS
	-	BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV
Falco A.	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
Falcou A.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Faleri M.L.	-	CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS
Falkensammer G.	-	UNEXPLAINED HIGH D-DIMER
Falleni M.	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
Falvo M.R.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Fan L.	-	VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
	-	STUDY OF ANTI-ANGIOGENESIS EFFECT INDUCED BY MER IN VITRO AND ITS MECHANISM
Fang W.	-	CLINICAL STUDY OF MULTI-LOCUS B-FIBRINOGEN GENE POLYMORPHISMS
Fang J.	-	CORRECTION OF HAEMORRHAGIC DISORDERS AFFECTING PLATELETS: GENE THERAPY RESTORES HEMOSTASIS WITHIN A CANINE MODEL FOR GLANZMANN THROMBASTHENIA
Fang Y.	-	MOLECULAR MECHANISMS IN TWO CHINESE PATIENTS WITH INHERITED AFIBRINOGENEMIA
Fang J.	-	RECOMBINANT HUMAN HPA-1A ANTIBODIES FOR TREATMENT OF FETO-MATERNAL ALLO-IMMUNE THROMBOCYTOPENIA (FMAIT): PROOF OF PRINCIPLE IN AN IN VIVO MURINE MODEL
Fantini F.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
Fantl D.	-	ASSESSMENT OF THE EFFECTIVENESS AND SECURITY OF HOME TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN IN ARGENTINA
Faradji A.	-	LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
	-	POSTMARKETING SURVEILLANCE STUDY OF SUCROSE-FORMULATED RECOMBINANT FACTOR VIII FOR SEVERE HEMOPHILIA A: FINAL RESULTS
Faranoush M.	-	EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	THROMBOSIS IN BETA THALASSEMIA MAJOR
Fard-Esfahani P.	-	FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS
Fareed J.	-	DIFFERENTIAL ACTIVATION OF PROTHROMBIN BY FACTOR XA, TAIPAN VENOM AND ECARIN. PHARMACOLOGIC IMPLICATIONS
	-	UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
Fareed D.	-	COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME
Fareed J.	-	COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME
	-	GLYCOPROTEIN IIB/IIIA RECEPTOR DENSITY MEASUREMENT. IMPLICATIONS IN THE MONITORING OF ANTIPLATELET DRUGS
	-	EFFECT OF ANTIDEPRESSANT DRUG TREATMENT ON INFLAMMATORY AND PLATELET ACTIVATION BIOMARKERS IN DEPRESSION
Fareed D.	-	UPREGULATION OF NITRIC OXIDE AND ASYMMETRIC DIMETHYLARGININE LEVELS IN MALIGNANCY ASSOCIATED THROMBOSIS AND THEIR MODULATION BY ANTICOAGULANTS
Fareed J.	-	UPREGULATION OF NITRIC OXIDE AND ASYMMETRIC DIMETHYLARGININE LEVELS IN MALIGNANCY ASSOCIATED THROMBOSIS AND THEIR MODULATION BY ANTICOAGULANTS
	-	UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY
Fareed D.	-	BETAINE (TRIMETHYLGLYCINE), A NOVEL ORAL ANTICOAGULANT WITH COMBINED NITRIC OXIDE AND TISSUE FACTOR PATHWAY INHIBITOR RELEASE POTENTIAL. IMPLICATIONS IN THE MANAGEMENT OF VASCULAR DISEASES
Fareed J.	-	BETAINE (TRIMETHYLGLYCINE), A NOVEL ORAL ANTICOAGULANT WITH COMBINED NITRIC OXIDE AND TISSUE FACTOR PATHWAY INHIBITOR RELEASE POTENTIAL. IMPLICATIONS IN THE MANAGEMENT OF VASCULAR DISEASES
	-	DIFFERENTIATION OF LOW MOLECULAR WEIGHT HEPARINS AS STUDIED BY MOLECULAR WEIGHT PROFILE AND HEPARINASE-I DEPOLYMERIZATION: PHARMACOLOGIC IMPLICATIONS
	-	FACTOR V REMOVAL FROM BOVINE THROMBIN USED AS A TOPICAL HEMOSTAT IN SURGERY: IMPROVED PURITY THROUGH A NEW MANUFACTURING PROCESS
	-	DENGUE FEVER AND THROMBOCYTOPENIA: A DEADLY DUO
	-	PREGNANCY ASSOCIATED ALTERATIONS OF THE INFLAMMATORY MEDIATORS, TISSUE FACTOR PATHWAY INHIBITOR AND PROTEIN Z
	-	UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
Fareed D.	-	RECOMBINANT THROMBOMODULIN DOES NOT CROSS REACT WITH ANTI-HEPARIN PLATELET FACTOR 4 ANTIBODIES. POTENTIAL IMPLICATION FOR ANTICOAGULATION OF HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS
Fareed J.	-	RECOMBINANT THROMBOMODULIN DOES NOT CROSS REACT WITH ANTI-HEPARIN PLATELET FACTOR 4 ANTIBODIES. POTENTIAL IMPLICATION FOR ANTICOAGULATION OF HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS
	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
	-	TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
Fareed D.	-	NITRIC OXIDE LEVELS ARE INCREASED FOLLOWING BRACHYTHERAPY COMPARED TO STENTING. IMPLICATIONS IN CORONARY RESTENOTIC COMPLICATIONS
Fareed J.	-	NITRIC OXIDE LEVELS ARE INCREASED FOLLOWING BRACHYTHERAPY COMPARED TO STENTING. IMPLICATIONS IN CORONARY RESTENOTIC COMPLICATIONS
	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
	-	RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS
	-	PREVALENCE OF CROSS-REACTIVE EPITOPES TO BOVINE FACTOR VA LIGHT CHAIN FRAGMENTS IN NORMALS AND END STAGE RENAL DISEASE PATEINTS
	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
	-	UPREGULATION OF MYELOPEROXIDASE IN END STAGE RENAL DISEASE AND ITS MODULATION BY HEMODIALYSIS
	-	PROTEINOMIC PROFILING OF TISSUE FACTOR MEDIATED PROTHROMBIN ACTIVATION PRODUCTS AND THEIR INHIBITION BY DIRECT ANTITHROMBIN AND ANTI-XA AGENTS
	-	SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION
	-	ARGATROBAN IS CAPABLE OF PASSING THROUGH THE BLOOD BRAIN BARRIER. POTENTIAL IMPLICATIONS IN THE MANAGEMENT OF THROMBOTIC STROKE
	-	DEFIBROTIDE MEDIATED INHIBITION OF HEPARINASE I. POTENTIAL CLINICAL IMPLICATIONS
	-	THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
	-	THE PHARMACOKINETICS OF DEFIBROTIDE IN NON-HUMAN PRIMATES IS DOSE DEPENDENT
Fareed D.	-	DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
Fareed J.	-	DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
	-	DIFFERENCES IN THE OLIGOSACCHARIDE COMPOSITION OF GENERIC VERSIONS OF ENOXAPARIN AND DALTEPARIN
	-	INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
	-	DEFIBROTIDE AND ITS MOLECULAR FRACTIONS DO NOT CROSS-REACT WITH HIT ANTIBODIES. IMPLICATIONS IN THE MANAGEMENT OF HIT
	-	ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
Farías C.	-	TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC
Farias F.	-	COMPARATIVE "IN VITRO" CHARACTERIZATION OF DIFFERENT PROTHROMBIN COMPLEX CONCENTRATES
Farías C.E.	-	EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
Farias C.	-	VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
	-	AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Farid N.A.	-	EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
Farina G.	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Farkas K.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Farnarier C.	-	UNIQUE RECIPROCAL MAP KINASE REGULATION IN THROMBIN-INDUCED ENDOTHELIAL PRO-INFLAMMATORY ACTIVATION
Farndale R.W.	-	THE USE OF ATOMIC FORCE MICROSCOPY TO STUDY COLLAGEN-PLATELET INTERACTIONS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
	-	NITRIC OXIDE INHIBITS ADHESION TO COLLAGEN BY MODULATING SENSITIVITY TO PLATELET DERIVED SECONDARY AGONISTS
	-	INVESTIGATION OF PLATELET BINDING TO COLLAGEN PEPTIDES UNDER FLOW CONDITIONS
	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
	-	IDENTIFICATION OF CRITICAL RESIDUES IN A GPVI BINDING PEPTIDE
	-	LIGAND-RECEPTOR AFFINITY AND RHO-FAMILIY GTPASES IN INTEGRIN ALPHA2BETA1-MEDIATED PROCESSES
	-	CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN
	-	PHOSPHOPROTEIN PROFILING OF COLLAGEN PEPTIDE ACTIVATED PLATELETS: A FOCUS ON SERINE AND THREONINE PHOSPHORYLATION EVENTS
	-	PLATELET RECEPTOR RECOGNITION AND CROSSTALK IN COLLAGEN-INDUCED ACTIVATION OF PLATELETS
	-	GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
	-	ACTIVATION OF PLATELETS BY A VON WILLEBRAND FACTOR-BINDING PEPTIDE SEQUENCE PRESENT IN COLLAGEN III
	-	GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
Farnia G.	-	RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF ACUTE POST PARTUM HEMORRHAGE: THE ITALIAN REGISTRY
Farren T.	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Farrugia C.	-	ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
Farrugia R.	-	MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
Farzan M.	-	THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS
Farzana T.	-	USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
Fasnacht M.	-	SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS
Fassler R.	-	ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Fässler R.	-	HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
Fatini C.	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
Fattohy S.	-	PATIENTS WITH METABOLIC SYNDROME DEMONSTRATE HIGH PLATELET REACTIVITY AND INCREASED PROCOAGULANT MARKERS
Fattore G.	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Faude S.	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Faulkner L.	-	A FLUOROGENIC THROMBIN GENERATION TEST (FTGT) FOR FACTOR VIII ACTIVITY DEMONSTRATED SUCCESS OF CELL THERAPY WITH LIVER SINUSOIDAL ENDOTHELIAL CELLS (LSEC) IN HAEMOPHILIA A MICE
Faurie-Bonnafous C.	-	TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE
Faust P.	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
Fauvel-Lafève F.	-	THE KOGEOGPK PEPTIDE FROM TYPE III COLLAGEN INHIBITS BREAST ADENOCARCINOMA CELL ADHESION TO TYPE III COLLAGEN AND HUVEC MATRIX IN WHOLE BLOOD AND UNDER FLOW CONDITIONS
	-	TYPE III COLLAGEN BINDING PROTEIN (TIIICBP) IS IDENTICAL TO KINDLIN-3, A PROTEIN BELONGING TO A NOVEL FAMILY OF FOCAL ADHESION PROTEINS
Fauvel-Lafeve F.	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Favalli E.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
Favaloro E.J.	-	2B OR NOT 2B? DISPARATE DISCRIMINATION OF FUNCTIONAL VWF DISCORDANCE USING DIFFERENT ASSAYS OR METHODOLOGIES FOR VWF LEADS TO SUCCESS OR FAILURE IN THE EARLY IDENTIFICATION OF TYPE 2B VWD
	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Favaretto E.	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	THE ROLE OF D-DIMER AS A RISK FACTOR FOR OCCULT CANCER AND CARDIOVASCULAR EVENTS AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	RESIDUAL VENOUS OBSTRUCTION AND D-DIMER AS RISK FACTORS FOR RECURRENCE AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
	-	G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
	-	NO INCREASED SIGNS OF ATHEROSCLEROTIC ALTERATIONS IN CARRIERS OF INHERITED THROMBOPHILIA WITH OR WITHOUT PREVIOUS VENOUS THROMBOSIS
Favaro M.	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
Favaro P.	-	PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
Favier M.	-	SEVERE FACTOR XI DEFICIENCY IN A JEWISH CHILD CAUSED BY COMPOUND HETEROZYGOTY FOR A NOVEL NONSENSE MUTATION (TYR-14X, EXON 2) AND THE COMMON TYPE II MUTATION (GLU1 17X, EXON 5).L
Favier R.	-	SEVERE FACTOR XI DEFICIENCY IN A JEWISH CHILD CAUSED BY COMPOUND HETEROZYGOTY FOR A NOVEL NONSENSE MUTATION (TYR-14X, EXON 2) AND THE COMMON TYPE II MUTATION (GLU1 17X, EXON 5).L
	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Favreau F.	-	ASPIRIN PREVENTS PLATELET ACTIVATION AFTER CORONARY ARTERY BYPASS SURGERY DESPITE AN INCREASE IN THROMBOXANE A2 SYNTHESIS
Faxälv L.	-	IMAGING OF BLOOD PLASMA COAGULATION AND ITS PROPAGATION AT SURFACES
Fay P.	-	ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
Fay P.J.	-	LEU335 CONTRIBUTES TO THE EFFICIENT PROTEOLYSIS OF FACTOR VIIIA AT ARG336 CATALYZED BY ACTIVATED PROTEIN C
Fazakas F.	-	TRANSIENT ACTIVATION OF BLOOD COAGULATION FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE ELASTASE
Fazi Z.	-	EVALUATION OF THE RELATIONSHIP BETWEEN GESTATIONAL DIABETES MELLITUS AND A HISTORY OF POLYCYSTIC OVARIAN SYNDROME
Fazo N.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Feddern J.	-	LOW INCIDENCE OF INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS WITH HAEMOPHILIA A
	-	EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
	-	PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
	-	ABSENCE OF INHIBITOR FORMATION IN PREVIOUSLY TREATED HAEMOPHILIA A PATIENTS TREATED WITH A DOUBLE VIRUS INACTIVATED, PLASMA DERIVED FACTOR VIII/VWF CONCENTRATE IN PROSPECTIVE CLINICAL STUDIES
Federici A.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Federici A.B.	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Federici F.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Federici A.B.	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Federico L.	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
Fedi S.	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
Fedorova T.A.	-	RECOMBINANT COAGULATION FACTOR VIIA IN THERAPY OF MASSIVE POST-PARTUM BLEEDING AT PATIENT WITH IDIOPATHIC THROMBOCYTOPENIA (ITP)
Fedortseva R.F.	-	AN INCREASE OF CELL LETHALITY IN IRRADIATED VASCULAR ENDOTHELIUM AND PROBLEM OF HAEMOSTASIS
Fedotkina J.	-	D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS
Fedotova I.	-	RELATIONSHIP BETWEEN OXIDATIVE STRESS, ENDOTHELIAL INJURY AND COAGULATION ACTIVATION IN ADVANCED CHRONIC HEART FAILURE
	-	SIGNIFICANCE OF PLASMA THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION
Fefer P.	-	CLOPIDOGREL UNRESPONSIVENESS OVERCOME BY RELOADING: ASSESSEMENT BY PLATELET AGGREGOMETRY AND IMPACT-R [CONE AND PLATE(LET) ANALYZER]
Feijge M.A.H.	-	INHIBITION OF P2Y12 BY AZD6140 REDUCES THROMBUS FORMATION AND PROCOAGULANT ACTIVITY ON COLLAGEN AND ATHEROSCLEROTIC PLAQUES
	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
Feindt P.	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Feistritzer C.	-	ACTIVATED PROTEIN C LEADS TO CELL SURFACE ACCUMULATION OF CLEAVED PAR1 AND SUPPORTS PROTECTIVE SIGNALING EVEN IN THE PRESENCE OF THROMBIN
	-	ROLE OF PAR1 IN PROTECTIVE SIGNALING BY ACTIVATED PROTEIN C IN SYSTEMIC INFLAMMATION
Fekete A.	-	GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS
Fekih M.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Fekrat M.	-	EVALUATION OF THE HYPERLIPIDEMIA AND HYPERGLYCEMIA IN PROGESTERONE ONLY PILL USERS
	-	RISK FACTORS IN WOMEN WITH GESTATIONAL DIABETES MELLITUS(GDM)
Feldman P.A.	-	REMOVAL OF HUMAN PARVOVIRUS B19 FROM FACTOR IX BY VIRUS FILTRATION
Feldman L.	-	MECHANISMS ASSOCIATED WITH FAILURE OF THROMBOLYTIC THERAPY TO RECANALIZE THE INFARCT ARTERY IN ACUTE MYOCARDIAL INFARCTION
Felekis T.	-	A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS
Felice A.	-	`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN
Felices R.	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
Feliú Torres A.	-	TYPE 2B VON WILLEBRAND'S DISEASE. REPORT FROM A SINGLE CENTER IN ARGENTINA
	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
Felix S.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) AND DILATED CARDIOMYOPATHY (DCM) - PARALLELS IN THE PATHOGENESIS OF TWO SEVERE IMMUNE MEDIATED CARDIOVASCULARE DISORDERS
Fenclova M.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Feng G.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Feng Y.	-	A SURVEY ON THE PREVALENCE OF VENOUS THROMBOEMBOLIC DISEASES IN GUANGZHOU OF CHINA
	-	CLINICAL APPLICATION OF ACTIVATED RECOMBINANT HUMAN FACTOR ? IN CHINA
	-	EXPOSURE-CLINICAL OUTCOME MODELING AND SIMULATION TO FACILITATE DOSE SELECTION OF APIXABAN IN SUBJECTS UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT SURGERY
Fenger Eriksen C.	-	EVALUATION OF COAGULATION KINETICS USING THROMBELASTOGRAPHY
Fenneteau O.	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Fenu L.	-	ANTIPHOSPHOLIPID SYNDROME AND PORTABLE COAGULOMETERS
	-	PERIODICAL LABORATORY EVALUATION OF PORTABLE COAGULOMETERS
Ferandiz D.	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
Ferguson E.J.	-	ANTICARDIOLIPIN ANTIBODIES AND OUTCOME OF PREGNANCY A RETROSPECTIVE 3 YEAR STUDY
Fernandes A.P.S.M.	-	SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
	-	ASSOCIATION BETWEEN PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND SMOKING IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
	-	APO B ECORI AND INSERTION/DELETION POLYMORPHISMS IN BRAZILIAN YOUNG PATIENTS WITH ISQUEMIC STROKE
	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
Fernandes A.P.	-	LACK OF ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISM AND ATHEROMATOSIS EXTENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Fernandes A.P.S.M.	-	PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE
	-	PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND OTHER PARAMETERS INTERRELATED IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE
Fernandes A.P.	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS
Fernandes A.P.S.M.	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
Fernandez R.	-	CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN
Fernandez F.	-	ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Fernàndez J.A.	-	ACTIVATED PROTEIN C
Fernandez O.	-	MILD HAEMOPHILIA A (P. A1824T) ASSOCIATED WITH HEREDITARY COAGULATION FACTOR XII DEFICIENCY AND HETEROZYGOUS PROTHROMBIN 20210G/A MUTATION
Fernández J.A.	-	GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
Fernandez G.	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
Fernandez J.A.	-	ROLE OF PAR1 IN PROTECTIVE SIGNALING BY ACTIVATED PROTEIN C IN SYSTEMIC INFLAMMATION
Fernandez V.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Fernandez J.A.	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
Fernandez-Bello I.	-	RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Fernandez-G J.	-	EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
	-	BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
Fernandez-Morata R.	-	IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
Fernandez-Palazzi F.	-	USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
Fernando S.	-	REMOVAL OF HUMAN PARVOVIRUS B19 FROM FACTOR IX BY VIRUS FILTRATION
Ferrando F.	-	PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION
	-	ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
Ferrando M.	-	ATORVASTATIN NEUTRALIZED THE UP-REGULATION OF THROMBOSPONDIN INDUCED BY THROMBIN IN ENDOTHELIAL CELLS
Ferrante F.	-	PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
	-	HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY
Ferrara D.	-	ROLE OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS AND ENDOTHELIAL CELL ACTIVATION
Ferraresi P.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Ferrari R.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Ferrari S.E.	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Ferrari R.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Ferrari S.E.	-	IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Ferrari S.	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Ferrari D.	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
Ferrari G.	-	EDHIT: EVALUATION OF DERMATAN SULPHATE IN PREVENTION AND TREATMENT OF HEPARIN INDUCED THROMBOCYTOPENIA
Ferrari do Outeiro Bernstein M.A.	-	SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Ferrer F.	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
	-	JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
	-	PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
Ferrero S.	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
Ferro L.	-	DEFIBROTIDE DIRECTLY ENHANCE THE ACTIVITY OF PLASMIN
Ferro A.M.	-	COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN
	-	TREATMENT WITH RECOMBINANT ACTIVATED FVII DECREASES FVIII INHIBITOR TITLE
Ferro L.	-	DEFIBROTIDE MODULATES HEPARANASE EXPRESSION IN ENDOTHELIAL AND TUMOR CELLS: A POTENTIAL MECHANISM OF ACTION
	-	DEFIBROTIDE PROTECTS ENDOTHELIAL CELLS AGAINST STRESS-INDUCED CELL DEATH VIA INHIBITION OF THE EXTRINSIC APOPTOSIS PATHWAY
Ferroni P.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Ferrucci L.	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
	-	HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
Fesl E.	-	PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY
Feys H.B.	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
	-	NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO
	-	FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L)
	-	THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS
Feys H.	-	THE VWF-GPIB AXIS AS A THERAPEUTIC TARGET
Ffrench P.	-	ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
	-	MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS
	-	ANTI-BETA 2 GLYCOPROTEIN I ANTIBODIES ASSAYS: USE OF MONOCLONAL ANTIBODIES FOR CALIBRATION
	-	A NOVEL DYSFIBRINOGENEMIA DETECTED BY ELECTROPHORESIS IN A PATIENT PRESENTING WITH FAMILIAL VENOUS THROMBOEMBOLISM
Fiamoli V.	-	IS IT POSSIBLE TO TREAT SAFELY AND EFFECTIVELY DEEP VEIN THROMBOSIS WITH CONTINUOUS I.V. INFUSION OF LMWH IN CHILDREN?
	-	RFVIIA IS EFFECTIVE ALTERNATIVE TO APCC IN PROPHYLAXIS OF BLEEDING DURING IMMUNE TOLERANCE PROTOCOL IN HAEMOPHILIAC WITH INHIBITOR
Fieschi C.	-	ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Fiessinger J.	-	BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
Fiessinger J.N.	-	LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
Figini F.	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
Figus M.	-	BILATERAL THROMBOSIS OF POSTERIOR SHORT CILIORETINAL VESSELS IN A PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, HYPERHOMOCYSTEINE AND ETEROZIGOUS FOR MTHRF
Fijnheer R.	-	HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
	-	GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
	-	ACTIVE CONFORMATION OF VON WILLEBRAND FACTOR IN TTP IS NOT RESTRICTED TO ULTRA-LARGE MULTIMERS
	-	THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY
Fijnvandraat K.K.	-	OVERWEIGHT IN DUTCH HAEMOPHILIA PATIENTS
Fijnvandraat K.	-	FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A
Filipov P.	-	PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Filippini M.	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
Filippucci E.	-	EDHIT: EVALUATION OF DERMATAN SULPHATE IN PREVENTION AND TREATMENT OF HEPARIN INDUCED THROMBOCYTOPENIA
	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
	-	EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY
Fimbel B.	-	IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES?
Fimiani M.	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
Finazzi G.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Findeklee J.	-	SUCCESSFUL INHIBITOR-ELIMINATION W ITH RITUXIMAB IN ONE PATIENT WITH A CARRIER STATE FOR HEMOPHILIA A AND 4 PATIENTS WITH ACQUIRED HEMOPHILIA A
Finger C.	-	RISK DETERMINANTS OF NONARTERITIC ISCHEMIC OPTIC NEUROPATHY (NAION)
Finkelstein T.S.	-	DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
Finkelstein Y.	-	DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
Finkelstein T.S.	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Finkelstein Y.	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Finn A.V.	-	MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI)
Fiore L.D.	-	SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
Fiorica A.	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Firbas C.	-	EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
	-	EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Fischer S.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
	-	INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Fischer J.	-	LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA
Fischer K.	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
Fischer R.	-	DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
Fischer C.	-	CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Fischer A.	-	RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
Fischer A.M.	-	SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
Fischer E.	-	RIVAROXABAN A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR ENHANCED THE ANTITHROMBOTIC EFFECTS OF CLOPIDOGREL IN RATS
Fischer C.	-	FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
Fischer A.M.	-	A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES
Fischer A.	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Fischer E.	-	AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL
Fischer R.	-	THROMBOPHILIA AND SPONTANEOUS ABORTION THERAPY WITH LMW-HEPARI
	-	THROMBOPHILIA AND SPONTANEOUS ABORTION THERAPY WITH LMW-HEPARI
Fischer A.M.	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
Fischer R.	-	GIESSEN THROMBOPHILIA STUDY: MANIFESTATION AGE OF THROMBOEMBOLISM IN THROMBOPHILIA
Fischer D.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
Fischer K.G.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
	-	HEMODIALYSER MEMBRANES ALLOW FOR REMOVAL OF ARGATROBAN
Fischer L.	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Fischer A.M.	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
Fischer K.	-	PHENOTYPE HETEROGENEITY IN SEVERE HAEMOPHILIA
Fischer E.	-	COMBINING RIVAROXABAN WITH ACETYLSALICYLIC ACID INCREASES ANTITHROMBOTIC POTENCY WITHOUT AFFECTING BLEEDING TIMES IN ANIMAL MODELS
Fischer K.	-	WASHOUT PERIOD AND FVIII:C IN PATIENTS WITH SEVERE HEMOPHILIA A
Fischer A.G.	-	PHARMACOKINETICS OF DALTEPARIN IN PROPHYLACTIC DOSAGE IN PATIENTS WITH IMPAIRED RENAL FUNCTION
Fischer A.M.	-	PLATELET MICROPARTICLES ARE A PREDICTIVE FACTOR OF OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER
Fisgin T.	-	CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY
Fish R.J.	-	FLUVASTATIN INHIBITS REGULATED SECRETION OF ENDOTHELIAL CELL VON WILLEBRAND FACTOR IN RESPONSE TO DIVERSE SECRETAGOGUES
	-	ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES
	-	THE REGULATION OF ENDOTHELIAL CELL T-PA PRODUCTION BY FLUVASTATIN
Fisher W.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Fisseau C.	-	VON WILLEBRAND FACTOR (VWF)-BINDING TO COLLAGEN III UNDER PHYSIOLOGICAL FLOW CONDITIONS AND VWF-MEDIATED PLATELET BINDING
Fitch R.M.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Fitzgerald D.J.	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
FitzGerald G.	-	EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY
Fitzgerald D.J.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
Fitzmaurice D.A.	-	BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
Fitzpatrick P.	-	MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
	-	THE MECHANO-REGULATION OF LASP-1 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Flake A.W.	-	OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
Flan B.	-	EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
	-	CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING
Flaujac C.	-	EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY
	-	BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS
	-	PLATELETS AND VIRUSES
Flaumenhaft R.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
	-	A NOVEL FAMILY OF ALKYLATED QUINOLINES INHIBITS G PROTEIN-COUPLED RECEPTORS WITH PALMITOYLATED CYTOPLASMIC TAILS
Fleites G.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Fletcher J.P.	-	BLEEDING COMPLICATIONS ASSOCIATED WITH PHARMACOLOGICAL PROPHYLAXIS FOR MAJOR ORTHOPAEDIC SURGERY
	-	VENOUS THROMBOEMBOLISM AND GYNAECOLOGICAL ONCOLOGY SURGERY
	-	PRACTICE PATTERNS IN PREVENTION OF VENOUS THROMBOEMBOLISM IN PRIMARY TOTAL HIP ARTHROPLASTY PATIENTS
	-	VENOUS THROMBOEMBOLISM PROPHYLAXIS IN CRITICALLY-ILL SURGICAL PATIENTS
Fletcher J.	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
Fleury R.	-	THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
	-	THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
Flierl U.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
Flinterman L.E.	-	RECURRENT VENOUS THROMBOSIS OF THE UPPER EXTREMITY
Fløisand Y.	-	HUMAN PLATELETS AND MEGAKARYOCYTES CONTAIN FACTOR X mRNA, DETECTED WITH REAL-TIME QUANTITATIVE RT-PCR
Flommersfeld S.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Flores M.P.A.	-	CLONING, ANALYSIS AND STRUCTURAL PREDICTION OF LOSAC, A NEW HEMOLIN FROM LONOMIA OBLIQUA
Flores-Nascimento M.C.	-	DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA
	-	ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
Florian M.	-	PROTEINOMIC PROFILING OF TISSUE FACTOR MEDIATED PROTHROMBIN ACTIVATION PRODUCTS AND THEIR INHIBITION BY DIRECT ANTITHROMBIN AND ANTI-XA AGENTS
	-	DIFFERENTIAL ACTIVATION OF PROTHROMBIN BY FACTOR XA, TAIPAN VENOM AND ECARIN. PHARMACOLOGIC IMPLICATIONS
Florquin S.	-	UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
Flynn G.	-	USE OF A HUMAN-DERIVED D-DIMER PREPARATION IN EXTERNAL QUALITY ASSESSMENT (EQA)
	-	D-DIMER REPORTING: WHAT'S THE PROBLEM FOR THE ELECTRONIC HEALTH RECORD? AN ONTARIO PERSPECTIVE
Foa A.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
Foekens J.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Foley J.H.	-	THE TIME COURSES OF FIBRIN FORMATION, PROTHROMBIN ACTIVATION AND TAFI ACTIVATION IN NORMAL AND FACTOR VIII-DEFICIENT PLASMA
Folkeringa N.	-	INCREASED TAFI LEVELS AND THE RISK OF THROMBOEMBOLISM
	-	THROMBIN ACTIVATBLE FIBRINOLYSIS INHIBITOR (TAFI) IS NOT ASSOCIATED WITH FETAL LOSS; A RETROSPECTIVE STUDY
Follenzi A.	-	A FLUOROGENIC THROMBIN GENERATION TEST (FTGT) FOR FACTOR VIII ACTIVITY DEMONSTRATED SUCCESS OF CELL THERAPY WITH LIVER SINUSOIDAL ENDOTHELIAL CELLS (LSEC) IN HAEMOPHILIA A MICE
Folsom A.R.	-	COAGULATION FACTORS IX - XIII AND RISK OF FUTURE VENOUS THROMBOSIS: THE LONGITUDINAL INVESTIGATION OF THROMBOEMBOLISM ETIOLOGY (LITE)
Fonnesu B.	-	TIME COURSE OF COAGULATION FACTORS IN OVERT DISSEMINATED INTRAVASCULAR COAGULATION: A CASE STUDY
Font C.	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Fontaine S.	-	DETECTION OF HYPERCOAGULABILITY IN PATIENTS WITH THYROID CANCER
	-	HIGH CONCENTRATION OF PROCOAGULANT PHOSPHOLIPIDS AND THROMBOMODULIN ACTIVITY ARE FOUND IN PREGNANCY COMPLICATIONS
Fontana P.	-	INFLUENCE OF CYP2C19 AND CYP3A4 GENE POLYMORPHISMS ON CLOPIDOGREL RESPONSIVENESS IN HEALTHY SUBJECTS
Fontana L.	-	ROLE OF 4G/5G PROMOTER POLYMORPHISM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OUTCOME OF SEPSIS
Fontayne A.	-	PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA
	-	THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS
Fontcuberta J.	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
	-	CLINICAL MANAGEMENT USING LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN PREGNANT WOMEN WITH THROMBOPHILIA, THROMBOEMBOLIC DISEASE (DVT) OR THROMBOPHILIA-RELATED MATERNOPLACENTAL SYNDROME: EXPERIENCE IN ONE CENTER
	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
	-	MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
	-	THROMBIN GENERATION ASSAY (TGA) CORRECTION IN VITRO AFTER ADDITION OF THERAPEUTIC RANGE DOSES OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) TO PLASMA SAMPLES WITH INR 5
	-	FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS
	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
	-	CLINICAL OUTCOMES DURING BEMIPARIN POST-MARKETING OBSERVATIONAL STUDIES ON PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
	-	WHAT IS THE CLINICAL IMPACT OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DEFICIENCY?
	-	A RANDOMIZED, CONTROLLED, DOUBLE BLIND STUDY OF BEMIPARIN VS UNFRACTIONATED HEPARIN AS BRIDGING THERAPY OF ORAL ANTICOAGULATION THERAPY IN INVASIVE PROCEDURES OR AMBULATORY SURGERY. DESIGN OF THE BERTA STUDY
	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Fontela T.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Forastiero R.R.	-	CORRELATION BETWEEN DIFFERENT FIBRINOLYTIC TESTS IN PATIENTS WITH OBSTETRIC COMPLICATIONS
Forastiero R.	-	THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY
Forastiero R.R.	-	EFFECTS OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FROM APL PATIENTS WITH APS OR WITH LEPROSY IN AN IN VIVO MODEL OF APS
	-	EVALUATION OF LIPOPROTEIN (A) IN ARGENTINIAN WOMEN WITH ADVERSED PREGNANCY OUTCOME
	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Force A.	-	DETECTION OF LARGE DELETIONS IN HAEMOPHILIA A: CARRIER DETECTION BY MP/LC (MULTIPLEX PCR/LIQUID CHROMATOGRAPHY)
Ford I.	-	POTENTIALLY PRO-THROMBOTIC ASSOCIATIONS BETWEEN PLATELET AND ENDOTHELIAL FUNCTION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
	-	ARTERIAL STIFFNESS, ENDOTHELIAL FUNCTION AND THE RISK OF ISCHAEMIC STROKE
	-	PLATELET ACTIVATION INCREASES WITH THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE: IMPLICATIONS FOR CLINICAL MANAGEMENT
Ford C.	-	ANTICOAGULANT MANAGEMENT USING AN INTERNET BASED MONITORING SYSTEM
Fordham D.	-	REMOVAL OF PORCINE PARVOVIRUS SPIKED INTO SAMPLES OF HUMAN RECOMBINANT FACTOR VIII
Forestier M.	-	PERSISTENT PLATELET MICROPARTICLE FORMATION IN THE PRESENCE OF BLOCKERS OF GP IBALPHA, GPIIB/IIIA, CALCIUM CHELATORS AND ADP SCAVENGERS UNDER HIGH SHEAR STRESS
Forgie M.A.	-	DEFINING BENEFIT-RISK TRADEOFF VALUES FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
	-	SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
Fornara L.	-	CARDIOVASCULAR DISEASE, HYPERHOMOCYSTEINEMIA AND ATHEROTHROMBOTIC RISK FACTORS IN PSORIATIC PATIENTS
Forneris G.	-	RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
Forster R.J.	-	S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
Forster A.	-	VERY LOW FREQUENCY OF HEPARIN INDUCED THROMBOCYTOPENIA (HIT) IN A TERTIARY CARE HOSPITAL
Forsyth A.	-	JOINT RANGE OF MOTION (ROM) MEASUREMENTS IN PATIENTS WITH VON WILLEBRAND DISEASE COMPARED WITH NORMAL SUBJECTS
Fort A.	-	NEONATAL LENTIVIRAL GENE TRANSFER IN A KNOCK-OUT MOUSE MODEL FOR AFIBRINOGENEMIA
Fortenberry Y.M.	-	RNA APTAMER-DIRECTED ANTICOAGULANT THERAPY
Foster W.	-	RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS
Foster T.J.	-	STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
Foster W.	-	ANGIOGENESIS IN RHEUMATOID ARTHRITIS: IS IT RELATED TO ENDOTHELIAL PERTURBATION AND/OR INFLAMMATION?
Foteeva T.S.	-	APPLICATION OF AUTOLOGOUS RED BLOOD CELLS CONCENTRATE DERIVED FROM UMBILICAL CORD BLOOD FOR THERAPY OF ANAEMIC NEONATES
Fouassier M.	-	SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
Fournel M.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
	-	PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
Fournier D.J.	-	INACTIVATION OF ALPHA-1-PROTEASE INHIBITOR DURING CLINICAL SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IS NOT CONSISTENT WITH INHIBITOR POLYMERIZATION
Fournier L.	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
Fox M.A.	-	POST-THROMBOTIC SYNDROME AFTER VENA CAVA FILTER PLACEMENT: A SYSTEMATIC REVIEW
Fox M.L.	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
Fox K.A.	-	IMPACT OF RENAL FUNCTION ON THE BENEFIT-RISK RATIO OF FONDAPARINUX IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES IN THE OASIS-5 TRIAL
Fox S.C.	-	MEASUREMENT OF ENDOTHELIAL MICROPARTICLES IN BLOOD IS IMPAIRED IF CHYLOMICRONS ARE PRESENT AFTER A FATTY MEAL
	-	RAISED LEVELS OF CD39 IN LEUCOCYTOSIS RESULT IN MARKED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION VIA RAPID ADP HYDROLYSIS
	-	EFFECTS OF A FLAVANOL-RICH COCOA BEVERAGE ON PLATELET AND LEUCOCYTE FUNCTION IN MAN
Fox S.	-	PLATELET AGGREGATION IS ENHANCED UNDER CONDITIONS OF HYPOTHERMIA
Foy M.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
Fraga C.M.	-	NEW THIENYLACYLHYDRAZONE DERIVATIVES AS CYCLIC NUCLEOTIDES MODULATORS AND PLATELET AGGREGATION INHIBITORS
Fragasso A.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Frame V.B.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Frampton J.	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
	-	IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB
Franchi F.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Franchini M.	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
Francis J.L.	-	BLOOD-BORNE BUT NOT ENDOTHELIAL CD40 PROMOTES EXPERIMENTAL LUNG METASTASIS
	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
Francis C.W.	-	FIBRINOGEN SYNTHESIZED BY CANCER CELLS AUGMENTS THE PROLIFERATIVE EFFECT OF FGF-2
Francis J.	-	THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Francis C.W.	-	INCREASING RATE OF VENOUS THROMBOEMBOLISM AMONG HOSPITALIZED CANCER PATIENTS
Francis S.E.	-	INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
Francis J.L.	-	ANTI-METASTASIS EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN EXPERIMENTAL METASTASIS MODEL
Francis C.W.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Francis J.L.	-	PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Francis J.	-	IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
Francis C.W.	-	DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR CHEMOTHERAPY-ASSOCIATED THROMBOSIS
Francque S.	-	THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER
Frangioni J.V.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
Franke B.	-	ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH
Frankova H.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Franssen E.J.F.	-	PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS
Fraone J.M.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Fraser C.	-	FACTOR V AND THROMBIN INHIBITORS IN CHILDREN FOLLOWING BOVINE THROMBIN EXPOSURE
Frasson R.	-	THE Na+-BOUND AND Na+-FREE CONFORMATION OF THROMBIN PROBED BY SOLUTION STUDIES
Frati L.	-	EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
Frazier O.	-	PLATELET AND MONOCYTE ACTIVATION IN PATIENTS UNDERGOING CIRCULATORY SUPPORT WITH LEFT VENTRICULAR ASSIST DEVICES (LVAD)
Fredenburgh J.C.	-	HISTIDINE-RICH GLYCOPROTEIN (HRG) MODULATES THE FUNCTION OF FXII IN HEMOSTASIS
	-	BIVALENT BINDING OF THROMBIN TO GAMMA'-FIBRIN ENHANCES PROTECTION FROM INHIBITION BY ANTITHROMBIN-HEPARIN
	-	ANTICOAGULANT PROPERTIES OF HD1, A (PRO)THROMBIN-DIRECTED DNA APTAMER
	-	ZINC PROMOTES FORMATION OF TERNARY THROMBIN-FIBRIN-HEPARIN COMPLEXES BY ENHANCING HEPARIN-FIBRIN AFFINITY
Frederix K.	-	THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS
	-	LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB
	-	CHARACTERIZATION OF THE ROLE OF PLATELET ADHESION MOLECULES IN A MURINE MODEL OF PHOTOSENSITIZER-INDUCED STROKE
Freedman J.	-	INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
	-	PLATELET ACTIVATION RESPONSE IS MORE SENSITIVE TO THROMBIN STIMULATION THAN IS PLATELET APOPTOSIS
Freedman J.J.	-	HEMOSTASIS IN FACTOR VIII DEFICIENT MICE IS IMPROVED AFTER THE INFUSION OF MONOCYTE-DERIVED MICROPARTICLES
Freedman J.	-	PLATELETS AND INNATE IMMUNITY
	-	BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
	-	ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
	-	IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
Fregatova L.M.	-	D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS
Fregin A.	-	IN VIVO-ASSAY FOR WARFARIN-RESISTANCE BY COEXPRESSION OF VKORC1 AND VITAMIN K-DEPENDENT COAGULATION FACTORS
Freire C.	-	THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Frelinger III A.L.	-	TARGETED INHIBITION OF THE SEROTONIN 5-HT2A RECEPTOR ATTENUATES RECURRENT PLATELET-MEDIATED THROMBOSIS IN AN IN VIVO MODEL MIMICKING UNSTABLE ANGINA
	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
French K.	-	WHAT DO ELEVATED D-DIMER LEVELS MEAN IN PATIENTS WITHOUT VENOUS THROMBOSIS (VTE)?
French FVIII SD-35-15 Study Group	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
French VWF SD-35-DH Study Group	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Frenkel E.J.	-	MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS
Frentzou A.	-	THE INFLUENCE OF TISSUE FACTOR ON OESTROGEN RECEPTOR ALPHA EXPRESSION AND CELL INVASION IN BREAST CANCER CELLS
	-	THE ABILITY OF TF TO PROMOTE TUMOUR CELL IMMUNE EVASION, MEDIATED VIA SURFACE VCAM-1
	-	DIFFERENTIAL EXPRESSION OF TF IN CARDIAC HYPERTROPHY AND ITS INVOLVEMENT IN THE PROGRESSION OF THE DISEASE
Frère C.	-	RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Frere C.	-	CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Freson K.	-	DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS
	-	THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA
	-	SEVERE GASTRO-INTESTINAL BLEEDING AND THROMBOCYTOPENIA DUE TO AN ANTI-GATA AUTOANTIBODY
	-	HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY
Fressinaud E.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	CAN THROMBIN GENERATION BE HELPFUL TO EVALUATE THE BLEEDING PHENOTYPE IN MILD HEMOPHILIA A WITH FACTOR VIII ASSAY DISCREPANCY?
Fretigny M.	-	MRNA ANALYSIS IN A SEVERE HAEMOPHILIA A PATIENT: DETECTION OF AN EXON 6 SKIPPING
	-	DETECTION OF LARGE DELETIONS IN HAEMOPHILIA A: CARRIER DETECTION BY MP/LC (MULTIPLEX PCR/LIQUID CHROMATOGRAPHY)
	-	CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B
Freund M.	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
	-	REDUCED ATHEROSCLEROTIC LESIONS IN P2Y1/APOE DOUBLE KNOCKOUT MICE
	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
Freund S.M.V.	-	THROMBIN IS A ZYMOGEN-LIKE ENZYME
Freyburger G.	-	COMPONENTS OF VARIABILITY OF D DIMER MEASUREMENT CLOSE TO THE CUT-OFF VALUE
	-	ESTIMATING THE INFLUENCE OF MEASUREMENT VARIABILITY ON DIAGNOSTIC ERRORS: A BAYESIAN MODEL APPLIED TO QUANTITATIVE D DIMER ASSAYS FOR THE EXCLUSION OF VENOUS THROMBOSIS
Freyssinet J.	-	SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS
Freyssinet J.M.	-	THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Freyssinet J.	-	ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Friboulet A.	-	KINETICS OF HYDROLYSIS BY FVIII HYDROLYZING ANTIBODIES IN ACQUIRED HEMOPHILIA A
	-	IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
Fribourg C.	-	ROLE OF THE ALPHA-HELIX 163-170 IN FACTOR XA CATALYTIC ACTIVITY
	-	CHARACTERIZATION OF THE INTERACTION BETWEEN VON WILLEBRAND FACTOR AND OSTEOPROTEGERIN
Fric E.	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Friedman K.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Friedman C.	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
Friedman K.D.	-	CORRELATIONS BETWEEN ADAMTS13 ACTIVITY AND INHIBITOR LEVELS: OBSERVATIONS AND IMPLICATIONS FOR RESOURCE UTILIZATION
Friedman C.	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
Friedman R.J.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Friedrich L.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Frieling J.T.M.	-	MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA IN HEREDITARY AT DEFICIENT PATIENTS DURING SURGERY
	-	PREGNANT HEREDITARY ANTITHROMBIN DEFICIENT WOMEN REQUIRE A DISTINCT DOSING STRATEGY FOR THE MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA
Friese K.	-	GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
Frigato E.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
Frigo M.	-	RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF ACUTE POST PARTUM HEMORRHAGE: THE ITALIAN REGISTRY
Friso S.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Fritsch S.	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION
	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT
	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
Fritsche I.	-	INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
Fritsma G.A.	-	COMPARISON OF TWO ANTI-XA ASSAYS USING A SINGLE CALIBRATION CURVE FOR MONITORING HEPARIN ANTICOAGULATION
	-	COMPARISON OF SINGLE AND SEVEN-DAY ASPIRIN PLATELET RESPONSE REVEALS DOSAGE EFFECT AT 81 AND 325 MG
Froesner G.	-	ANTIVIRAL TREATMENT OF HCV INFECTED YOUNG HAEMOPHILIACS AN UPDATE OF 14 YEARS EXPERIENCE IN A PRIVATE PRACTICE CCC
Froloshki B.S.	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Frontroth J.P.	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
	-	TYPE 2B VON WILLEBRAND'S DISEASE. REPORT FROM A SINGLE CENTER IN ARGENTINA
Frost C.	-	APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
	-	APIXABAN, AN ORAL DIRECT, FACTOR XA INHIBITOR: SINGLE-DOSE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Frosticks S.P.	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Frühauf A.	-	THERAPY OF ACQUIRED HEMOPHILIA HAS CYTOTOXIC AND RITUXIMAB TREATMENT TO BE COMBINED WITH IMMUNOADSORPTION?
	-	PLASMA CONCENTRATIONS OF TISSUE FACTOR AND COAGULATION FACTOR XIIA IN PREGNANT WOMEN
Fryer H.J.L.	-	QUANTIFICATION OF ADAMTS13 ANTIGEN, ACTIVITY AND ADAMTS13/FXI COMPLEX FROM PATIENTS WITH HEMOSTATIC/THROMBOTIC DISORDERS
	-	CHARACTERIZATION OF ADAMTS13/FXI COMPLEX FROM PLASMA AND QUANTITATION BY ELISA IN NORMAL DONORS AND TTP PATIENTS
Fryer J.	-	THE USE OF ADVATE IN LIVER AND KIDNEY TRANSPLANTATION IN A PATIENT WITH HEMOPHILIA A, HEPATITIS C, AND HIV
Fryer H.	-	A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
Fu Z.	-	COMPARISON OF EFFICACY AND SAFETY OF INTRAVENOUS AND INTRA-ARTERIAL THROMBOLYSIS IN ACUTE ISCHEMIC STROKE
Fu J.	-	QUANTITATIVE ANALYSIS OF GENE EXPRESSION FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS APPLICATION
Fucharoen S.	-	PROTEIN C MUTATIONS IN THAI PATIENTS WITH VENOUS THROMBOEMBOLISM
Fuchs B.	-	VON WILLEBRAND FACTOR (VWF)-BINDING TO COLLAGEN III UNDER PHYSIOLOGICAL FLOW CONDITIONS AND VWF-MEDIATED PLATELET BINDING
Fuerll B.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
Fugazza A.	-	ACCURACY AND COST EVALUATION OF A PORTABLE INR MONITOR
Fujie T.	-	PROLONGED HEMOSTATIC ABILITY OF POLY(ETHYLENE GLYCOL)-MODIFIED POLYMERIZED ALBUMIN PARTICLES CARRYING FIBRINOGEN-GAMMA CHAIN DODECAPEPTIDE
Fujihara N.	-	MARKEDLY IMPAIRED BUT SIGNIFICANT THROMBIN-CATALYZED FIBRIN POLYMERIZATION OBSERVED AT VARIANT FIBRINOGENS AT GAMMA364ASP RESIDUE IS ARISEN FROM B-KNOB AND B-HOLE BONDING
Fujii T.	-	ROLE OF ANGIOPOIETIN(ANG)-1/TIE-2 SIGNALING PATHWAY FOR ANG-2 EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Fujii K.	-	REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
Fujii T.	-	VEGF FUNCTION FOR UPREGULATION OF ENDOGENOUS PLGF EXPRESSION DURING FGF-2-MEDIATED THERAPEUTIC ANGIOGENESIS
Fujikawa K.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Fujimori Y.	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Fujimura Y.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
	-	IMMUNO-PURIFICATION OF PLASMA ADAMTS13 AND ITS PHYSICO-CHEMICAL CHARACTERIZATION
	-	ANALYSIS OF ADAMTS13 IN PATIENTS WITH COLLAGEN DISEASE-ASSOCIATED TMAS
Fujisawa D.	-	IDENTIFICATION OF VEGF RECEPTOR-BINDING SITES OF KDR-BINDING PROTEIN
Fujita T.	-	THE GENETIC ANALYSIS OF DEEP VEIN THROMBOSIS DURING PREGNANCY AND PERINATAL ASSOCIATED DISORDERS IN JAPANESE
Fujita S.	-	CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Fukuda T.	-	ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE, RECOMBINANT FACTOR VIII AND FACTOR IX REVERSE PROLONGED CLOTTING TIME INDUCED BY DU-176B, A DIRECT FACTOR XA INHIBITOR, IN HUMAN PLASMA
	-	COMPARISON OF ANTITHROMBOTIC PROPERTIES OF A DIRECT FXA INHIBITOR, DU-176B, WITH AN ANTITHROMBIN DEPENDENT FXA INHIBITOR, FONDAPARINUX, IN A CAPILLARY PERFUSION CHAMBER THROMBOSIS MODEL
	-	EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
Fukuoka A.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Fukutake K.	-	ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION
	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
	-	FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
	-	CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
Fulfaro F.	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
Fuller N.	-	THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
	-	PLATELET FACTOR V DEFICIENCY IN A PATIENT WITH AN ACQUIRED INHIBITOR OF VA PROCOAGULANT FUNCTION
Fuller G.L.J.	-	THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
Funk W.D.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
	-	RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER
	-	RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER
Furie B.C.	-	THROMBIN-INITIATED PLATELET ACTIVATION IN VIVO IS VON WILLEBRAND FACTOR INDEPENDENT DURING THROMBUS FORMATION IN A LASER INJURY MODEL
Furie B.	-	THROMBIN-INITIATED PLATELET ACTIVATION IN VIVO IS VON WILLEBRAND FACTOR INDEPENDENT DURING THROMBUS FORMATION IN A LASER INJURY MODEL
Furie B.C.	-	INACTIVE TISSUE FACTOR CONTAINING EXPOSED THIOLS RESIDES ON THE SURFACE OF UNSTIMULATED ENDOTHELIAL CELLS
Furie B.	-	INACTIVE TISSUE FACTOR CONTAINING EXPOSED THIOLS RESIDES ON THE SURFACE OF UNSTIMULATED ENDOTHELIAL CELLS
Furie B.C.	-	EXPRESSION OF PROTEIN DISULFIDE ISOMERASE DURING THROMBUS FORMATION
Furie B.	-	EXPRESSION OF PROTEIN DISULFIDE ISOMERASE DURING THROMBUS FORMATION
Furie B.C.	-	BSDL INTERACTS WITH THE PLATELET CXCR4 AND MODULATES THROMBUS FORMATION
Furie B.	-	BSDL INTERACTS WITH THE PLATELET CXCR4 AND MODULATES THROMBUS FORMATION
Furie B.C.	-	CANCER-ASSOCIATED THROMBOSIS: TISSUE FACTOR-BEARING MICROPARTICLES ARE ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLIC EVENTS IN CANCER PATIENTS
Furie B.	-	CANCER-ASSOCIATED THROMBOSIS: TISSUE FACTOR-BEARING MICROPARTICLES ARE ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLIC EVENTS IN CANCER PATIENTS
Furie B.C.	-	IN VIVO THROMBUS FORMATION
Furie B.	-	IN VIVO THROMBUS FORMATION
Furie B.C.	-	IN VIVO MONITORING OF THROMBUS FORMATION
Furie B.	-	IN VIVO MONITORING OF THROMBUS FORMATION
Furihata K.	-	INFLUENCE OF PLATELET GP6 HAPLOTYPES (GP6A AND GP6B)
Furlan Freguia C.	-	PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
	-	IN VIVO EFFECTS OF MURINE AND HUMAN APC
	-	NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
	-	MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A
Furmedge J.	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
Furugohri T.	-	EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
Furusaki F.	-	ADAMTS13 AND VON WILLEBRAND FACTOR IN THE PATIENTS WITH DIC
Furusako S.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Fuse I.	-	CHARACTERISTIC FEATURES OF SOLUBLE FIBRIN (SF) AND SOLUBLE FIBRIN MONOMER COMPLEX (FMC) AS MEASURED BY IMMUNOASSAYS WITH IATRO SF AND AUTO LIAFM, RESPECTIVELY
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
Fuset M.M.P.	-	INSUFFICIENT INHIBITION OF PLATELET THROMBOXANE SYNTHESIS IS ASSOCIATED WITH GREATER CORONARY ARTERY DISEASE EVALUATED BY ANGIOGRAPHY
Fuset M.	-	DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING
	-	EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
	-	EPINEPHRINE REDUCES THE EFFECT OF ANTIPLATELET THERAPIES IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). ROLE OF PI3K
Fuxman C.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION

| ISTH 2009